Literature DB >> 18690276

Reassessment of evidence synthesis of occupational medicine practice guidelines for interventional pain management.

Laxmaiah Manchikanti1, Vijay Singh, Richard Derby, David M Schultz, Ramsin M Benyamin, Joshua P Prager, Joshua A Hirsch.   

Abstract

BACKGROUND: Appropriately developed practice guidelines present statements of best practice based on a thorough evaluation of the evidence from published studies on the outcomes of treatments, which include the application of multiple methods for collecting and evaluating evidence for a wide range of clinical interventions and disciplines. However, the guidelines are neither infallible, nor a substitute for clinical judgment. While the guideline development process is a complex phenomenon, conflict of interest in guideline development and inappropriate methodologies must be avoided. It has been alleged that the guidelines by the American College of Occupational and Environmental Medicine (ACOEM) prevent injured workers from receiving the majority of medically necessary and appropriate interventional pain management services. An independent critical appraisal of both chapters of the ACOEM guidelines showed startling findings with a conclusion that these guidelines may not be applied in patient care as they scored below 30% in the majority of evaluations utilizing multiple standardized criteria.
OBJECTIVE: To reassess the evidence synthesis for the ACOEM guidelines for the low back pain and chronic pain chapters utilizing an expanded methodology, which includes the criteria included in the ACOEM guidelines with the addition of omitted literature and application of appropriate criteria.
METHODS: For reassessment, randomized trials were utilized as it was in the preparation of the guidelines. In this process, quality of evidence was assessed and recommendations were made based on grading recommendations of Guyatt et al. The level of evidence was determined utilizing the quality of evidence criteria developed by the U.S. Preventive Services Task Force (USPSTF), as well as the outdated quality of evidence criteria utilized by ACOEM in the guideline preparation. Methodologic quality of each individual article was assessed utilizing the Agency for Healthcare Research and Quality (AHRQ) methodologic assessment criteria for diagnostic interventions and Cochrane methodologic quality assessment criteria for therapeutic interventions.
RESULTS: The results of reassessment are vastly different from the conclusions derived by the ACOEM guidelines. The differences in strength of rating for the diagnosis of discogenic pain by provocation discography and facet joint pain by diagnostic facet joint nerve blocks is established with strong evidence. Therapeutic cervical and lumbar medial branch blocks and radiofrequency neurolysis, therapeutic thoracic medial branch blocks, cervical interlaminar epidural steroid injections, caudal epidural steroid injections, lumbar transforaminal epidural injections, percutaneous and endoscopic adhesiolysis, and spinal cord stimulation qualified for moderate to strong evidence. Additional insight is also provided for evidence rating for intradiscal electrothermal therapy (IDET), automated percutaneous disc decompression, and intrathecal implantables.
CONCLUSION: The reassessment and reevaluation of the low back and chronic pain chapters of the ACOEM guidelines present results that are vastly different from the published and proposed guidelines. Contrary to ACOEM's conclusions of insufficient evidence for most interventional techniques, the results illustrate moderate to strong evidence for most diagnostic and therapeutic interventional techniques.

Entities:  

Mesh:

Year:  2008        PMID: 18690276

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  8 in total

1.  Analysis of run-in and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich plasma gel on healing trajectory.

Authors:  Marissa J Carter; Carelyn P Fylling; William W Li; Jean de Leon; Vickie R Driver; Thomas E Serena; Janice Wilson
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

2.  Ultrasound versus fluoroscopy-guided cervical medial branch block for the treatment of chronic cervical facet joint pain: a retrospective comparative study.

Authors:  Ki Deok Park; Dong-Ju Lim; Woo Yong Lee; JaeKi Ahn; Yongbum Park
Journal:  Skeletal Radiol       Date:  2016-11-04       Impact factor: 2.199

3.  Pathophysiology, diagnosis, and treatment of discogenic low back pain.

Authors:  Bao-Gan Peng
Journal:  World J Orthop       Date:  2013-04-18

4.  Risk factors related to accidental intravascular injection during caudal anesthesia.

Authors:  Keita Fukazawa; Yuka Matsuki; Hiroshi Ueno; Toyoshi Hosokawa; Munetaka Hirose
Journal:  J Anesth       Date:  2014-05-14       Impact factor: 2.078

Review 5.  Epidural steroid injections in the management of low-back pain with radiculopathy: an update of their efficacy and safety.

Authors:  Michel Benoist; Philippe Boulu; Gilles Hayem
Journal:  Eur Spine J       Date:  2011-09-16       Impact factor: 3.134

6.  Effect of Previous Caudal Block to Predict Successful Outcome after Adhesiolysis using a Steerable Catheter in Lumbar Failed Back Surgery Syndrome: A Retrospective Study.

Authors:  Ji Yeong Kim; Do-Hyeong Kim; Dong Woo Han; Young Chan Kim; Ji Young Lee; Young Kyung Park; Hue Jung Park
Journal:  Int J Med Sci       Date:  2022-06-06       Impact factor: 3.642

7.  Explosive growth of facet joint interventions in the Medicare population in the United States: a comparative evaluation of 1997, 2002, and 2006 data.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Vijay Singh; Mark V Boswell; Howard S Smith; Joshua A Hirsch
Journal:  BMC Health Serv Res       Date:  2010-03-30       Impact factor: 2.655

8.  Single-Shot Epidural Injections in the Management of Radicular Pain.

Authors:  Kourosh Zarghooni; Ali Rashidi; Jan Siewe; Marc Röllinghoff; Jan Bredow; Peer Eysel; Max J Scheyerer
Journal:  Orthop Rev (Pavia)       Date:  2015-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.